Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 152

1.

[Case of primary malignant lymphoma of the bladder].

Goto D, Otani T, Tomioka A, Maruyama Y.

Hinyokika Kiyo. 2013 Sep;59(9):583-6. Japanese.

2.

[A case of primary malignant lymphoma of the bladder].

Shinbo H, Nakanishi T, Suzuki K, Fujita K.

Hinyokika Kiyo. 1999 Oct;45(10):717-20. Japanese.

3.

[Primary malignant lymphoma of the urinary bladder: a case report].

Koike H, Morita T, Tamura Y.

Nihon Hinyokika Gakkai Zasshi. 2004 May;95(4):675-8. Japanese.

4.

[A case of secondary malignant lymphoma of the urinary bladder].

Yokoyama M, Kobayashi T, Kubo Y, Kageyama Y, Kihara K.

Hinyokika Kiyo. 2006 Apr;52(4):285-7. Japanese.

5.

Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in China: a 10-year retrospective follow-up analysis of 437 cases from Shanghai Lymphoma Research Group.

Li X, Liu Z, Cao J, Hong X, Wang J, Chen F, Wang C, Zou S, Li J, Shen Z.

Ann Hematol. 2012 Jun;91(6):837-45. doi: 10.1007/s00277-011-1375-0. Epub 2011 Dec 9.

PMID:
22160255
6.

[Primary diffuse large B-cell lymphoma of the uterine cervix successfully treated with rituximabplus cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy-a case report].

Hashimoto A, Fujimi A, Kanisawa Y, Matsuno T, Okuda T, Minami S, Doi T, Ishikawa K, Uemura N, Jyomen Y, Tomaru U.

Gan To Kagaku Ryoho. 2013 Dec;40(13):2589-92. Japanese.

PMID:
24335377
7.

Primary lymphoma of the bladder.

Leite KR, Bruschini H, Camara-Lopes LH.

Int Braz J Urol. 2004 Jan-Feb;30(1):37-9.

8.

Cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab versus epirubicin, cyclophosphamide, vinblastine, prednisone and rituximab for the initial treatment of elderly "fit" patients with diffuse large B-cell lymphoma: results from the ANZINTER3 trial of the Intergruppo Italiano Linfomi.

Merli F, Luminari S, Rossi G, Mammi C, Marcheselli L, Tucci A, Ilariucci F, Chiappella A, Musso M, Di Rocco A, Stelitano C, Alvarez I, Baldini L, Mazza P, Salvi F, Arcari A, Fragasso A, Gobbi PG, Liberati AM, Federico M.

Leuk Lymphoma. 2012 Apr;53(4):581-8. doi: 10.3109/10428194.2011.621565. Epub 2011 Nov 15.

PMID:
21895543
9.

Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma.

Musolino A, Boggiani D, Panebianco M, Vasini G, Salvagni S, Franciosi V, Ardizzoni A.

Cancer. 2011 Mar 1;117(5):964-73. doi: 10.1002/cncr.25582. Epub 2010 Oct 19.

10.

Malignant lymphoma of the vagina successfully treated with rituximab, adryamicin, cyclophosphamide, vincristine sulfate, and prednisolone.

Nasu K, Okamoto M, Nishida M, Takai N, Narahara H.

Eur J Gynaecol Oncol. 2012;33(2):219-22.

PMID:
22611969
11.

Strikingly high false positivity of surveillance FDG-PET/CT scanning among patients with diffuse large cell lymphoma in the rituximab era.

Avivi I, Zilberlicht A, Dann EJ, Leiba R, Faibish T, Rowe JM, Bar-Shalom R.

Am J Hematol. 2013 May;88(5):400-5. doi: 10.1002/ajh.23423. Epub 2013 Mar 19.

12.

Prognostic factors in primary diffuse large B-cell lymphoma of adrenal gland treated with rituximab-CHOP chemotherapy from the Consortium for Improving Survival of Lymphoma (CISL).

Kim YR, Kim JS, Min YH, Hyunyoon D, Shin HJ, Mun YC, Park Y, Do YR, Jeong SH, Park JS, Oh SY, Lee S, Park EK, Jang JS, Lee WS, Lee HW, Eom H, Ahn JS, Jeong JH, Baek SK, Kim SJ, Kim WS, Suh C.

J Hematol Oncol. 2012 Aug 13;5:49.

13.

Primary lymphoma of the bladder: a report of three cases.

Power RE, Kay EW, O'Connell F, Jaber AA, Donovan MG, Hickey DP, Creagh TA.

Ir J Med Sci. 2001 Jul-Sep;170(3):196-7.

PMID:
12120976
14.

[Case of primary malignant lymphoma of the liver treated by R-CHOP therapy].

Asagi A, Miyake Y, Ando M, Yasuhara H, Matsumoto K, Takahara M, Kawai D, Kaji E, Toyokawa T, Onishi T, Miyatani K, Nakatsu M.

Nihon Shokakibyo Gakkai Zasshi. 2009 Mar;106(3):389-96. Japanese.

PMID:
19262053
15.

R-CHOP therapy alone in limited stage diffuse large B-cell lymphoma.

Tomita N, Takasaki H, Miyashita K, Fujisawa S, Ogusa E, Matsuura S, Kishimoto K, Numata A, Fujita A, Ohshima R, Kuwabara H, Hagihara M, Hashimoto C, Takemura S, Koharazawa H, Yamazaki E, Fujimaki K, Taguchi J, Sakai R, Ishigatsubo Y.

Br J Haematol. 2013 May;161(3):383-8. doi: 10.1111/bjh.12281. Epub 2013 Feb 25.

PMID:
23432318
16.

[An atypical presentation of primary cutaneous diffuse B-cell lymphoma, leg type].

Brouillard C, Granel-Brocard F, Montagne K, Bastien C, Barbaud A, Schmutz JL.

Ann Dermatol Venereol. 2011 Aug-Sep;138(8-9):601-4. doi: 10.1016/j.annder.2011.02.020. Epub 2011 Apr 23. French.

PMID:
21893235
17.

Diffuse large B-cell lymphoma presenting as a sacral tumor. Report of two cases.

Liu JK, Kan P, Schmidt MH.

Neurosurg Focus. 2003 Aug 15;15(2):E10.

PMID:
15350041
18.

Primary diffuse large B-cell lymphoma of the mandible. A case report.

Pié-Sánchez J, Petit J, Figueiredo R, Gay-Escoda C.

Minerva Stomatol. 2011 Jan-Feb;60(1-2):87-92.

PMID:
21252853
19.
20.

Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma.

Fabbri A, Gozzetti A, Rigacci L.

Cancer. 2011 Aug 1;117(15):3530; author reply 3531. doi: 10.1002/cncr.25948. Epub 2011 Feb 1. No abstract available. Erratum in: Cancer. 2012 Jul 1;118(13):3446. Febbri, Alberto [corrected to Fabbri, Alberto].

Supplemental Content

Support Center